Active-Controlled Trial of the Safety and Tolerability of MP29-02 in Subjects with Chronic Allergic or Nonallergic Rhinitis

Trial Profile

Active-Controlled Trial of the Safety and Tolerability of MP29-02 in Subjects with Chronic Allergic or Nonallergic Rhinitis

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Feb 2013

At a glance

  • Drugs Azelastine/fluticasone-propionate (Primary) ; Fluticasone propionate
  • Indications Perennial allergic rhinitis; Rhinitis; Vasomotor rhinitis
  • Focus Adverse reactions; Registrational
  • Sponsors Meda Pharmaceuticals
  • Most Recent Events

    • 06 Mar 2012 Results presented at the 68th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 05 Mar 2012 Status changed from not stated to completed, according to a Meda media release.
    • 31 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top